Jasper Therapeutics Inc. (JSPR)
NASDAQ: JSPR
· Real-Time Price · USD
2.92
-0.19 (-6.11%)
At close: Aug 18, 2025, 3:59 PM
2.97
1.71%
After-hours: Aug 18, 2025, 05:14 PM EDT
-6.11% (1D)
| Bid | 2.97 |
| Market Cap | 43.86M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -78.78M |
| EPS (ttm) | -6.05 |
| PE Ratio (ttm) | -0.48 |
| Forward PE | -0.68 |
| Analyst | Buy |
| Ask | 3.1 |
| Volume | 311,058 |
| Avg. Volume (20D) | 659,132 |
| Open | 3.13 |
| Previous Close | 3.11 |
| Day's Range | 2.90 - 3.13 |
| 52-Week Range | 2.27 - 26.05 |
| Beta | 2.71 |
About JSPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol JSPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for JSPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+21.85%
Jasper Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
1 month ago
-55.1%
Jasper Therapeutics shares are trading lower after the company reported an 89% response rate in its Urticaria study and will halt the program.
1 month ago · https://www.marketscreener.com
Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash RunwayJasper Therapeutics, Inc. announced a corporate reorganization to extend its cash runway, including a workforce reduction of approximately 50%. Jasper has refined its operating plan to focus on its br...
